Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Guangyuan Hu
Tongji Hospital
Principal Investigator - Guochun Cao
Jiangsu Cancer Institute & Hospital
Principal Investigator - Meiyu Fang
Cancer Hospital of The University of Chinese Academy of Sciences
Principal Investigator - Qingyuan Zhang
The Second Affiliated Hospital of Harbin Medical University
Principal Investigator - Shubin Wang
Peking University Shenzhen Hospital
Principal Investigator - Wei Wang
Hunan Cancer Hospital
Principal Investigator - Xiaohui He
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator - Yan Sun
Peking University Cancer Hospital & Institute
Principal Investigator - Ye Guo, PhD
Shanghai East Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shanghai Henlius Biotech Inc.
Shanghai, Shanghai Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jul 2020
- Primary completion
- 30 May 2024
- Completion
- 30 Jun 2025
- Last update posted
- 8 Aug 2023
- Registered enrollment
- 131
- Registry id
- NCT04297995
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.